A company that likely specializes in the research, development, and application of bioluminescence technologies. Bioluminescence refers to the production and emission of light by living organisms. This can be applied in various fields such as biotechnology, medical diagnostics, environmental monitoring, and research.

Bioluminescence

Bioluminescence Ventures is a biotechnology venture firm investing in Drug Discovery Platforms (Oncology, Immunology, Neuroscience, Genetic Diseases), Applied Biology Platforms, and Computational Biology Platforms. The firm has AUM of $550M+ with offices in San Francisco and Cambridge (MA). 

Biomedical research is entering a Golden Age of Discovery – industrialized by HW/SW technologies, powered by longitudinal multi-modal data sets, and translated into novel therapies / therapeutic modalities by a new generation of multidisciplinary scientific founders. Bioluminescence was conceptualized and launched to potentiate this next generation of translational founders. Patient impact is our guiding light, and we see this light radiating from exceptional translational founders. Our growing team of multidisciplinary biotechnology researcher-operator-investors seek to earn trust through a shared understanding of the science and a shared vision for its potential to address unmet clinical needs. We seek to provide technical support as they translate and develop their science. We seek to provide financing support through the long and arduous journey. We also seek to provide business advisory and development support as the science matures toward co-development and co-commercialization partnerships. By obsessively and comprehensively meeting the needs of our founders, we aim to maximize their downstream impact on patients. We aim to make their light shine brighter.

For more information, please visit Bioluminescence.com.

Bioluminescence Ventures

Looking forward to a productive #JPM2023! If you'd like to connect or learn more about Bioluminescence Ventures, please reach out to info@bioluminescence.com 

#bioluminescence #biotechnology #JPMWeek

Metric
Company Name	Bioluminescence
Symbol
MSH ID	COM:BIOLUMINESCENCE
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage
Employee Count	4
Website	bioluminescence.com
LinkedIn	bioluminescence-ventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	10.19
28-Day Growth Score	13.66
90-Day Growth Score	14.89
365-Day Growth Score	12.86

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:BIOLUMINESCENCE

Bioluminescence

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue